Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001529224-17-000001
Filing Date
2017-01-05
Accepted
2017-01-05 16:27:41
Documents
1
Effectiveness Date
2017-01-05
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8303
  Complete submission text file 0001529224-17-000001.txt   9375
Mailing Address 280 SOUTH MANGUM STREET SUITE 350 DURHAM NC 27701
Business Address 280 SOUTH MANGUM STREET SUITE 350 DURHAM NC 27701 (919) 215-5962
GeneCentric Diagnostics, Inc. (Filer) CIK: 0001529224 (see all company filings)

EIN.: 452540158 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-277741 | Film No.: 17511076